Janssen Pharmaceuticals
(Redirected from Janssen Biotech)
Janssen Pharmaceuticals is a pharmaceutical company that is a subsidiary of the multinational corporation, Johnson & Johnson. It was founded by Dr. Paul Janssen in 1953 in Belgium and has since grown to become one of the world's leading pharmaceutical companies.
History
Janssen Pharmaceuticals was founded by Dr. Paul Janssen, a Belgian researcher, in 1953. The company was initially focused on research and development of innovative pharmaceuticals. In 1961, it was acquired by Johnson & Johnson, a multinational corporation based in the United States. Since then, Janssen Pharmaceuticals has expanded its operations globally and has developed a wide range of pharmaceutical products.
Products
Janssen Pharmaceuticals has developed and marketed a wide range of pharmaceutical products. These include drugs for the treatment of schizophrenia, epilepsy, pain management, HIV/AIDS, hepatitis C, and cancer, among others. Some of the company's most well-known products include Risperdal, Prezista, and Remicade.
Research and Development
Janssen Pharmaceuticals is known for its strong commitment to research and development. The company invests heavily in R&D, with a focus on areas such as neuroscience, oncology, immunology, infectious diseases, and cardiovascular diseases. The company's R&D efforts have resulted in numerous breakthroughs and have contributed significantly to advances in medical science.
Controversies
Like many pharmaceutical companies, Janssen Pharmaceuticals has faced controversies. These have included lawsuits related to the marketing of its products, allegations of price gouging, and issues related to the safety and efficacy of some of its drugs.
See Also
References
Janssen_Pharmaceuticals
- Janssen Pharmaceuticals logo.svg
Janssen Pharmaceuticals logo
Janssen Pharmaceuticals facility in Leiden, 2021
Xian Janssen Pharmaceutical
Risperdal tablets
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
